A Study on the Treatment Period and Bone Turnover Markers According to Application of Teriparatide in the Treatment of Medication-Related Osteonecrosis of the Jaw

The administration of teriparatide (TPTD) shows good clinical outcomes in previously refractory medication-related osteonecrosis of the jaws (MRONJ). Bone turnover markers, factors involved in bone formation and resorption, are used to measure the activity of bone metabolism and are an important factor that assesses the onset of MRONJ and the prognosis for treatment.

Source: Journal of Oral and Maxillofacial Surgery - September 1, 2023 Category: ENT & OMF Authors: Jun-Young Kim Source Type: research